The pharmaceutical industry comes under Healthcare group. It’s a Non-commodity type industry.
Growing demand as lifestyles continue to become sedentary leading to particular disorders.
Inelastic demand for basic medicines for chronic illnesses.
Low R&D, trial and production costs especially for generics.
Access to foreign markets due to mergers and acquisitions and strategic tie-ups.
Uncertain government regulations on pricing
High competition from foreign companies
Dependence of regulators in developed markets
High risk of litigations and patents disputes especially in developed markets
Growing population with higher life expectancy and greater number of old people
Awareness of latest medicine technologies
Increasing lifestyle disorders such as diabetes, cardiac and obesity
Very strong demand for generics in developed and domestic markets due to its cheap pricing.
Growth in hospital and healthcare sector
Cipla is the third largest player in the Indian market, with business units including Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access.
The Company's geographical segments include India, USA, South Africa and Rest of the World.
Segments and Products
The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.
The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices.
Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health.
|ICICI Prudential Mutual Fund||3.660|
|HDFC Mutual Fund||2.459|
|Reliance Mutual Fund||1.422|
|SBI Mutual Fund||0.677|
|UTI Mutual Fund||0.557|
|JM Financial Mutual Fund||0.114|
|Quantum Mutual Fund||0.065|
|Kotak Mahindra Mutual Fund||0.026|
|Tata Mutual Fund||0.025|
|Invesco Mutual Fund||0.022|
Address: Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai, Maharashtra - 400013 | Phone: 022-24826000 / 022-24826951 | Fax: 022-24826893
Registrar & Transfer Agent: Karvy Computershare Pvt Ltd
Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: email@example.comWebsite: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153